ArticleThoracic cancer2020

Real-life effectiveness of first-line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry.

Kristian Brat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.